Intrinsic Value of S&P & Nasdaq Contact Us

Zynex, Inc. ZYXI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
63/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$14.38
+11404%

Zynex, Inc. (ZYXI) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 6 Buy, 3 Hold.

The consensus price target is $14.38 (low: $11.00, high: $18.00), representing an upside of 11404% from the current price $0.13.

Analysts estimate Earnings Per Share (EPS) of $0.20 and revenue of $0.20B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.09 vs est $0.20 (missed -55%). Analyst accuracy: 0%.

ZYXI Stock — 12-Month Price Forecast

$14.38
▲ +11,404.00% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Zynex, Inc., the average price target is $14.38, with a high forecast of $18.00, and a low forecast of $11.00.
The average price target represents a +11,404.00% change from the last price of $0.13.
Highest Price Target
$18.00
Average Price Target
$14.38
Lowest Price Target
$11.00

ZYXI Analyst Ratings

Buy
9
Ratings
6 Buy
3 Hold
Based on 9 analysts giving stock ratings to Zynex, Inc. in the past 3 months
Rating breakdown
Buy
6 67%
Hold
3 33%
67%
Buy
6 analysts
33%
Hold
3 analysts
0%
Sell
0 analysts

EPS Estimates — ZYXI

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $0.09 vs Est $0.20 ▼ 122.2% off
Profitability Outlook
Company is profitable but with thin earnings per share. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — ZYXI

96%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.192B vs Est $0.200B ▼ 4.0% off
Revenue Trend
Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message